You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphocyte activation gene 3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in

Not yet recruiting
  • Brain Ischemia
  • Serum Iron
  • +7 more
  • Aswan, Egypt
    Aswan University Hospital
Mar 7, 2023

Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Bladder Urothelial

Not yet recruiting
  • Muscle Invasive Bladder Urothelial Carcinoma
  • +3 more
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Aug 10, 2023

Nasopharyngeal Carcinoma Trial (procedure, drug, biological)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Sep 12, 2023

Cutaneous Melanoma, Mucosal Melanoma, Ocular Melanoma Trial in New York, Houston (biological, other, procedure)

Active, not recruiting
  • Cutaneous Melanoma
  • +10 more
  • Ipilimumab
  • +4 more
  • New York, New York
  • +1 more
Aug 25, 2021

Tumors by Site Trial in Worldwide (Relatlimab, Nivolumab, BMS-986213)

Active, not recruiting
  • Neoplasms by Site
  • Relatlimab
  • +2 more
  • La Jolla, California
  • +52 more
Feb 10, 2022

Advanced Cancer Trial in Chengdu, Hangzhou (TQB2223 injection+ Penpulimab Injection)

Recruiting
  • Advanced Cancer
  • TQB2223 injection+ Penpulimab Injection
  • Chengdu, Sichuan, China
  • +1 more
Jun 7, 2023

Solid Tumor, Adult Trial (EOC202, albumin-bound paclitaxel)

Not yet recruiting
  • Solid Tumor, Adult
  • EOC202
  • albumin-bound paclitaxel
  • (no location specified)
Apr 7, 2022

HIV Infection Primary Trial in Badalona (Dasatinib 70 mg, Placebo)

Not yet recruiting
  • HIV Infection Primary
  • Dasatinib 70 mg
  • Placebo
  • Badalona, Barcelona, Spain
    Hospital Universitari Germans Trias i Pujol
Mar 9, 2023

Lymphocytes of Polymyalgia Patients

Completed
  • Polymyalgia Rheumatica
  • Blood samples before and after standard of care of polymyalgia rheumatica
  • (no location specified)
Jan 11, 2023

X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Suspended
  • X-linked Severe Combined Immunodeficiency (XSCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

Adult Solid Tumor Trial (HLX26, HLX10)

Recruiting
  • Adult Solid Tumor
  • Xuzhou, Jiangsu, China
    Xuzhou Central Hospital
Oct 17, 2022

Solid Tumor, Adult, Lymphoma Trial in Shanghai (HLX26)

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 10, 2022

Advanced Malignant Tumors(Stage IA-IB) Trial in Beijing (AK129 IV infusion)

Not yet recruiting
  • Advanced Malignant Tumors(Stage IA-IB)
  • AK129 IV infusion
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Science
Jan 17, 2023

TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid

Not yet recruiting
  • TIA
  • +2 more
  • Interleukin-2 [IL-2]
  • Standard care - Carotid Endarterectomy
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrookes Hospital
Aug 2, 2023

Pre-Eclampsia Trial (real time PCR)

Not yet recruiting
  • Pre-Eclampsia
  • real time PCR
  • (no location specified)
Mar 22, 2022

Lysosomal Diseases, Gangliosidosis, GM1 Trial run by the NHGRI (biological, drug, diagnostic test, other, procedure, behavioral)

Recruiting
  • Lysosomal Diseases
  • +2 more
  • AAV9-GLB1
  • +20 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Colorectal Cancer Metastatic Trial (HLX26, HLX10)

Not yet recruiting
  • Colorectal Cancer Metastatic
  • (no location specified)
Oct 14, 2022

Glioblastoma Trial in Atlanta, Bethesda (Nivolumab, BMS-986016)

Recruiting
  • Glioblastoma
  • Atlanta, Georgia
  • +1 more
Sep 21, 2022

Extramembranous Glomerulopathy Trial in Nice (Blood sample)

Recruiting
  • Extramembranous Glomerulopathy
  • Blood sample
  • Nice, France
    Centre Hospitalier Universitaire de Nice
Jun 20, 2022

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 31, 2022

Solid Tumor, Cutaneous Squamous Cell Carcinoma, Endometrial Cancer Trial (favezelimab/pembrolizumab, pembrolizumab, lenvatinib)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • favezelimab/pembrolizumab
  • +2 more
  • (no location specified)
Sep 7, 2023

Unresectable Cutaneous Melanoma, Metastatic Cutaneous Melanoma Trial in Worldwide (Sintilimab + IBI110)

Withdrawn
  • Unresectable Cutaneous Melanoma
  • Metastatic Cutaneous Melanoma
  • Sintilimab + IBI110
  • San Francisco, California
  • +12 more
Nov 16, 2022

Melanoma Trial in Loma Linda, Bethesda (Intervention Arm, Control)

Recruiting
  • Melanoma
  • Intervention Arm
  • Control
  • Loma Linda, California
  • +1 more
Aug 24, 2022

Hemodialysis Complication Trial (CBC and flow cytometry test for monocyte)

Not yet recruiting
  • Hemodialysis Complication
  • CBC and flow cytometry test for monocyte
  • (no location specified)
May 24, 2023